跳转至内容
Merck
CN
所有图片(1)

文件

416154

Sigma-Aldrich

Isoginkgetin

≥98% (HPLC), solid, pre-mRNA splicing inhibitor, Calbiochem®

别名:

前体mRNA剪接抑制剂,异银杏双黄酮

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C32H22O10
CAS号:
分子量:
566.51
MDL编号:
UNSPSC代码:
12352200
NACRES:
NA.77

product name

前体mRNA剪接抑制剂,异银杏双黄酮, The Pre-mRNA Splicing Inhibitor, Isoginkgetin, also referenced under CAS 548-19-6, blocks the spliceosome-meidated splicing process.

质量水平

检测方案

≥98% (HPLC)

形式

solid

制造商/商品名称

Calbiochem®

储存条件

OK to freeze
protect from light

颜色

yellow

溶解性

DMSO: 100 mg/mL

运输

ambient

储存温度

2-8°C

InChI

1S/C32H22O10/c1-39-18-6-3-15(4-7-18)26-14-24(38)31-22(36)12-21(35)29(32(31)42-26)19-9-16(5-8-25(19)40-2)27-13-23(37)30-20(34)10-17(33)11-28(30)41-27/h3-14,33-36H,1-2H3

InChI key

HUOOMAOYXQFIDQ-UHFFFAOYSA-N

一般描述

一种细胞可渗透的,天然分离的银杏双黄酮类化合物,通过在前剪接体/A复杂阶段阻断对剪接体介导的剪接过程,作为一般的前mRNA剪接抑制剂(在使用HeLa核提取物的剪接测定中,ICmax = 50 µM)。已显示异银杏素治疗以可逆的方式导致HEK293衍生的培养物中的生长停滞,而不会影响细胞活率(33 µM持续24 h)。
天然分离的银杏双黄酮类化合物,通过阻止前剪接体A复合物募集U4/U5/U6 tri-snRNP(稳定的核RNA及其相关蛋白)形成B复合物,作为剪接体介导的前mRNA剪接的细胞可渗透,可逆抑制剂(在使用HeLa核提取物的剪接测定中,IC50和ICmax分别为30和50 µM)。已显示异银杏素治疗以可逆的方式导致HEK293衍生的培养物中的生长停滞,而不会影响细胞活率(33 µM持续24 h)。

包装

用惰性气体包装

警告

毒性:标准处理(A)

其他说明

Kim, H.Y., et al. 2008.Arch.Pharm. Res.31, 265.
O′Brien, K., et al. 2008.J. Biol. Chem.283, 33147.
Yoon, S,O., et al. 2006.Mol.Cancer Ther.5, 2666.

法律信息

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sang-Oh Yoon et al.
Molecular cancer therapeutics, 5(11), 2666-2675 (2006-11-24)
Matrix metalloproteinase (MMP)-9 plays a key role in tumor invasion. Inhibitors of MMP-9 were screened from Metasequoia glyptostroboides (Dawn redwood) and one potent inhibitor, isoginkgetin, a biflavonoid, was identified. Noncytotoxic levels of isoginkgetin decreased MMP-9 production profoundly, but up-regulated the
Wenbo Zhu et al.
ACS omega, 5(39), 25306-25311 (2020-10-13)
Deposition and dysfunction of U1 small nuclear ribonucleoprotein (snRNP) have been revealed in Alzheimer's disease (AD), but whether U1 is involved in the amyloid precursor protein (APP) and Tau pathways remains unclear. Here, we investigate this by inhibiting the U1
Kristine O'Brien et al.
The Journal of biological chemistry, 283(48), 33147-33154 (2008-10-02)
Membrane-permeable compounds that reversibly inhibit a particular step in gene expression are highly useful tools for cell biological and biochemical/structural studies. In comparison with other gene expression steps where multiple small molecule effectors are available, very few compounds have been
Hyun Pyo Kim et al.
Archives of pharmacal research, 31(3), 265-273 (2008-04-15)
Biflavonoids belong to a subclass of the plant flavonoid family. Distribution of biflavonoids in the plant kingdom is limited to several species. Previously, some pharmacological activities of biflavonoids were described such as inhibition of histamine release from mast cells and
Andrey A Parkhitko et al.
PLoS genetics, 17(2), e1009354-e1009354 (2021-02-17)
The RB1 tumor suppressor is recurrently mutated in a variety of cancers including retinoblastomas, small cell lung cancers, triple-negative breast cancers, prostate cancers, and osteosarcomas. Finding new synthetic lethal (SL) interactions with RB1 could lead to new approaches to treating

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门